EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Association between AST/ALT ratio and diabetic retinopathy risk in type 2 diabetes: a cross-sectional investigation

Xianhua Li, Wenqing Hao, Sen Lin, Nailong Yang

Frontiers in Endocrinology · 2024

DOI: 10.3389/fendo.2024.1361707 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Frontiers in Endocrinology, 2024. Verfasst von Xianhua Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Alanine Transaminase, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Aspartate Aminotransferases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to explore the association between the aspartate aminotransferase to alanine aminotransferase ratio (AST/ALT ratio) and diabetic retinopathy (DR) in patients with type 2 diabetes.

Methods

In this cross-sectional study, clinical data from 3002 patients with type 2 diabetes admitted to the Department of Endocrinology of our hospital between January 1, 2021, and December 1, 2022, were retrospectively collected. Measurements of AST and ALT were conducted and diabetes-related complications were screened. The association between AST/ALT ratio and diabetic retinopathy was assessed using multivariate logistic regression, and a generalized additive model (GAM) was used to investigate nonlinear relationships. Subgroup analyses and interaction tests were also conducted.

Results

Among the 3002 patients, 1590 (52.96%) were male and 1412 (47.04%) were female. The mean AST/ALT ratio was 0.98 ± 0.32, ranging from 0.37 (Min) to 2.17 (Max). Diabetic retinopathy was present in 40.47% of the patients. After multivariate adjustments, for each 0.1 unit increase in AST/ALT ratio, the risk of DR increased by 4% (OR = 1.04, 95% CI: 1.01–1.07, p=0.0053). Higher AST/ALT ratio quartiles were associated with Higher prevalence of DR (OR vs . Q1: Q4 = 1.34 (CI: 1.03–1.75, p=0.0303).The GAM and smoothed curve fit indicated a linear relationship between AST/ALT ratio and DR risk, with no significant interaction effects across different subgroups.

Conclusion

Our study demonstrates a positive correlation between the AST/ALT ratio and diabetic retinopathy risk in type 2 diabetes, suggesting its potential role in assessing DR risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alanine TransaminaseDiabetes Mellitus, Type 2Diabetic RetinopathyAspartate AminotransferasesFemaleHumansMaleCross-Sectional StudiesRetrospective StudiesBiomarkersRisk Factors

Stichwörter der Autor:innen

alanine transaminaseaspartate aminotransferasescorrelationdiabetes mellitusdiabetic retinopathytype 2

Substanzen

Alanine TransaminaseAspartate AminotransferasesBiomarkers

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Department of Nursing and Hospital Infection Management, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Department of Endocrinology and Diabetes Department, Shouguang People's Hospital, Weifang, Shandong, China.

Zitieren

APA

Li, X., Hao, W., Lin, S., & Yang, N. (2024). Association between AST/ALT ratio and diabetic retinopathy risk in type 2 diabetes: a cross-sectional investigation. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2024.1361707

Vancouver

Li X, Hao W, Lin S, Yang N. Association between AST/ALT ratio and diabetic retinopathy risk in type 2 diabetes: a cross-sectional investigation. Frontiers in Endocrinology. 2024. doi:10.3389/fendo.2024.1361707

BibTeX
@article{Li2024,
  author = {Li, Xianhua and Hao, Wenqing and Lin, Sen and Yang, Nailong},
  title = {Association between AST/ALT ratio and diabetic retinopathy risk in type 2 diabetes: a cross-sectional investigation},
  journal = {Frontiers in Endocrinology},
  year = {2024},
  doi = {10.3389/fendo.2024.1361707}
}
Kostenlos starten →